Rotterdam, The Netherlands
Boston, MA, USA
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
RAD-x is one of the leading European diagnostic imaging practice operators focusing on Germany and...
Performation is a provider of healthcare specific business intelligence solutions. Its software products enable clients...
KLIFO is a leading drug development consultancy with significant experience in partnering with biotech and...